What is Albinson Brock’s total Claritev (CTEV) share ownership after this Form 4 grant?

After the restricted stock unit grant, Albinson Brock beneficially owns 27,237 shares of Claritev Class A common stock directly. This total includes the effect of the newly awarded equity reported in the Form 4 filing.

Claritev SVP Granted 23,243 Restricted Stock Units

Claritev Corp reported that SVP and Chief Accounting Officer Albinson Brock acquired an equity award tied to 23,243 shares of Class A common stock as a grant of restricted stock units.

Accepted by SEC EDGAR 03/03/2026 - 06:01 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Claritev Corp reported that SVP and Chief Accounting Officer Albinson Brock acquired an equity award tied to 23,243 shares of Class A common stock as a grant of restricted stock units. These RSUs vest 25% each on March 1 of 2027, 2028, 2029 and 2030. Following this grant, Brock beneficially owns 27,237 shares directly.

Insider Trade Summary

Grant/Award: 23,243 shares

Grant/Award 1 txn

Insider Albinson Brock

Role SVP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A common stock	23,243	$0.00	$0.00

Holdings After Transaction: Class A common stock — 27,237 shares (Direct)

Footnotes (1)

F1. Represents a grant of restricted stock units which will vest at a rate of 25% per year on each of March 1, 2027, 2028, 2029, and 2030.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Claritev Corp (CTEV) disclose in Albinson Brock’s latest Form 4?

Claritev Corp disclosed that SVP and Chief Accounting Officer Albinson Brock received a grant of 23,243 restricted stock units. The award relates to Class A common stock and increases Brock’s directly held beneficial ownership to 27,237 shares after the transaction.

How many Claritev (CTEV) shares are covered by Albinson Brock’s new RSU grant?

The new grant covers restricted stock units tied to 23,243 shares of Claritev Class A common stock. These units represent additional potential equity ownership for Brock, subject to the vesting schedule disclosed in the Form 4 footnote.

What is the vesting schedule for Albinson Brock’s 23,243 Claritev (CTEV) RSUs?

The 23,243 restricted stock units vest in four equal installments of 25% each. Vesting occurs on March 1, 2027, March 1, 2028, March 1, 2029, and March 1, 2030, assuming applicable vesting conditions continue to be satisfied.

Was Albinson Brock’s Claritev (CTEV) RSU grant an open-market purchase or a compensation award?

The Form 4 characterizes the transaction as a grant, award, or other acquisition of 23,243 restricted stock units. The transaction code “A” and zero dollar price per share indicate it is an equity compensation award rather than an open-market share purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Albinson Brock

(Last)

(First)

(Middle)

C/O CLARITEV CORPORATION

7900 TYSONS ONE PLACE, SUITE 400

(Street)

MCLEAN

22102

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Claritev Corp [ CTEV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A common stock	03/01/2026		A⁽¹⁾		23,243	A	$0	27,237	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents a grant of restricted stock units which will vest at a rate of 25% per year on each of March 1, 2027, 2028, 2029, and 2030.

Remarks:

	/s/ Kent Bartholomew, attorney-in-fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR